.

OMEICOS Appoints Dr Simon Russell as CEO

Berlin, Germany, September 03, 2019 – OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, today announced that Dr Simon Russell has been appointed as Chief Business Officer.

Tonic App raises 3.5 million euros

August 27th 2019: Tonic App, the startup that developed the favourite mobile application of more than 12,000 medical doctors, has raised 3.5 million euros in a round co-led by Vesalius Biocapital Partners (Luxembourg) and Armilar Venture Partners (Portugal), joining Portugal Ventures and TheVentureCity.

Mecuris GmbH: Best MedTech Startup

Mecuris GmbH, a commercial-stage Munich-based medical technology startup focusing on the digitalization of prosthetics and orthotics, has been listed as one of the Best European MedTech Startups by Valuer. Vesalius Biocapital supports the innovative Mecuris approach since January 2019.

Forendo: Phase 1b Proof

Turku, Finland, August 20th 2019: Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women's health, today announces initiation of dosing in a Phase 1b clinical study in its lead endometriosis program with the aim to demonstrate Proof of Mechanism.

Sunstone Life Science joins Syndicate

Turku, Finland, July 19th 2019: Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women's health, today announces that Sunstone Life Science Ventures has made a €5 million investment in Forendo.

Investment in DEARhealth

AMSTERDAM 18 July 2019 - DEARhealth, a health tech spin-out from the University of California, Los Angeles (UCLA), today announced a first closing of its Series A round with Philips Health Technology Ventures, Vesalius Biocapital III and Health Innovations. DEARhealth offers Artificial Intelligence (AI)-powered health pathways for chronic care.

Schneider-Littfeld in Advisory Board

Munich, 04.07.2019 - The Munich based medical technology startup Mecuris GmbH won industry expert Johannes Schneider Littfeld as Chairman of the Advisory Board. The company Mecuris offers a digital workshop for the creation and individualisation of prostheses and orthoses.

Final Close of EUR 120 million Fund

Luxembourg-Strassen, June 25, 2019 – Vesalius Biocapital III ('Vesalius'), the specialist life sciences venture capital investor, announces the final close of the VBC III fund securing EUR 120 million of equity commitments.

SWORD Health raises $8M funding

New York, Tuesday, 16th April 2019: SWORD Health, a tech-enabled physical therapy provider, has raised $8 million in a series A investment round led by Khosla Ventures and several other prominent angel investors. It will allow SWORD to focus on bringing its technology to more patients' homes and expand its footprint in the U.S. market.

Mecuris: Schindler as brand ambassador

Tuesday, 09 April 2019 – Paralympic cyclist Denise Schindler is new brand ambassador for Medtech startup Mecuris. The Paralympic cyclist and current Vice World Champion will be the face of Mecuris for the next four years.

.

xxnoxx_zaehler